The Future of Animal Health
SustentoBio Inc. is a veterinary biotechnology company dedicated to providing animals with the latest advancements in immunotherapeutics. Using a specially developed protein, our product is able to enhance the animal’s own immune system to fight solid tumors and infectious disease. The treatment is non-invasive, has no known side effects, is cost-effective, and is less painful than the current leading cellular treatment.
SUSTENTOBIO: MISSION
We believe pets should have access to the same type of therapies as humans … and at an affordable price.
SUSTENTOBIO: WHAT WE DO
Primary goals:
(1) to improve the quality of life for companion animals
(2) to extend the life expectancy of diseased animals
(3) to offer treatments at an affordable price
Indications:
Solid Tumors, Infectious Disease and Rejuvenation
MARKET: HUMANIZATION OF PETS
Over past two decades, dogs, cats and other companion animals have increasingly become an integral part of the family household.
-
67% of U.S. households, or about 85 million families own a pet.
-
95% of owners consider pets part of their family.
-
In older populations, pets are providing companionship.
-
In young adult population, pets are replacing the desire to have children.
Greater focus is placed on improving the lifestyle and well-being of pets.
-
Greater frequency of visits to the veterinarian.
-
Increased spending on healthcare.
CURRENT CANCER TREATMENTS
Surgical Excision
-
Invasive
-
Cannot address advanced stage disease
Radiation Therapy
-
Requires specialized equipment, not readily available
-
Unpredictable results
Chemotherapy (CHOP Protocol)
-
Many side effects, including lethargy
-
Unpredictable results
Cost of Treatment: $3,000 to $10,000
Post-Treatment Survival: 6 months